מיוויו

Country: Israel

Language: Hebrew

Source: Ministry of Health

Buy It Now

Active ingredient:

TETROFOSMIN

Available from:

ELDAN ELECTRONIC INSTRUMENTS CO LTD

ATC code:

V09GA02

Pharmaceutical form:

אבקה מיובשת בהקפאה להכנת תמיסה להזרקה

Composition:

TETROFOSMIN 0.23 MG/VIAL

Administration route:

תוך-ורידי

Prescription type:

מרשם נדרש

Manufactured by:

GE HEALTHCARE AS, NORWAY

Therapeutic area:

TECHNETIUM (99MTC) TETROFOSMIN

Therapeutic indications:

Indicated as an adjunct in the diagnosis and localization of myocardial ischaemia or infarction. Myoview is indicated as an adjunct to the initial assessments (e.g. palpation mammography or alternative imaging modalities and/or cytology) in characterisation of malignancy of suspected breast lesions where all these other recommended tests were inconclusive.

Authorization date:

2021-01-31

Documents in other languages

Public Assessment Report Public Assessment Report English 11-01-2021

Search alerts related to this product

View documents history